Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Latvia
Clinical trial register · European Union · CTIS

Clinical Trials in Latvia, 2026

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2554 most recently authorised of 12905 total CTIS records — a stated recency window, not the full historical archive. Synced 21 Nov 2026, 03:17 UTC
2554
Shown in this register
most recently authorised
12,905
Total on CTIS
full historical archive
780
Phase III
within the shown window
Top member states
Spain 1064 France 921 Germany 904 Italy 766 Poland 624 Netherlands 546

Trials with a site in Latvia

38 of 2554 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
Phase III
Pulmovant Inc.
Cardiovascular Diseases
France, Netherlands, Germany, Latvia, Sweden, Portugal, Belgium, Poland, Lithuania, Czechia, Greece
16/11/2026
Phase III
Vanda Pharmaceuticals Inc.
Digestive System Diseases
Czechia, Estonia, Bulgaria, Romania, Latvia, Poland
10/11/2026
Phase III
Nektar Therapeutics
Immune System Diseases
Portugal, Austria, Poland, Latvia, Italy, Czechia, Germany, Hungary, Croatia
03/11/2026
Phase I
Argenx
Musculoskeletal Diseases
Slovenia, Latvia, Denmark, Germany, Belgium, Norway, Spain, Poland, Lithuania, Italy, France, Netherlands
27/10/2026
Phase III
Vivus B.V., Vivus LLC
Respiratory Tract Diseases
Italy, France, Czechia, Poland, Latvia, Germany, Spain
05/10/2026
Phase III
Zydus Therapeutics Inc.
Digestive System Diseases
Ireland, Greece, Estonia, Netherlands, Bulgaria, Slovakia, Poland, Latvia, Croatia, Spain, France, Italy
05/10/2026
Phase III
Regeneron Pharmaceuticals Inc.
Cardiovascular Diseases
Portugal, Germany, Italy, Czechia, Austria, Spain, Belgium, Netherlands, Poland, Sweden, Greece, Latvia, Hungary, Bulgaria, Romania
29/09/2026
Phase III
Regeneron Pharmaceuticals Inc.
Cardiovascular Diseases
Spain, Bulgaria, Hungary, Poland, Romania, Sweden, Germany, Italy, Latvia, Netherlands, Portugal
29/09/2026
Phase III
Regeneron Pharmaceuticals Inc.
Hemic and Lymphatic Diseases
Spain, Slovakia, Hungary, Czechia, Romania, Estonia, Austria, France, Belgium, Sweden, Italy, Latvia, Poland, Bulgaria, Greece, Germany, Denmark, Lithuania, Netherlands
29/09/2026
Phase III
Dianthus Therapeutics Inc.
Immune System Diseases
Czechia, Portugal, Austria, Bulgaria, Germany, France, Latvia, Poland, Italy, Spain, Denmark
28/09/2026
Phase IV
Urogen Pharma Ltd.
Neoplasms
Estonia, Romania, Spain, Bulgaria, Latvia
11/09/2026
Phase III
Laboratorios Farmaceuticos Rovi S.A.
Neoplasms
Romania, Spain, Bulgaria, Czechia, Latvia, Poland, Croatia, Slovakia
21/08/2026
Phase III
Amgen Inc.
Eye Diseases
Slovakia, Latvia, Czechia, Poland, Spain, Hungary, Lithuania
17/08/2026
Phase II
Cardurion Pharmaceuticals Inc.
Cardiovascular Diseases
Latvia, Slovakia, Lithuania, Hungary, Italy, Netherlands, Spain, Poland, Bulgaria, Czechia
14/08/2026
Phase III
Argenx
Hormonal diseases
Italy, Czechia, Spain, Denmark, Belgium, Romania, Latvia, France, Germany, Greece, Sweden, Poland, Lithuania, Bulgaria
07/08/2026
Phase III
Sanofi-Aventis Recherche & Developpement
Respiratory Tract Diseases
Denmark, Sweden, Poland, Estonia, Portugal, Latvia, Spain, Hungary, Germany, Finland, Italy, Belgium, France
06/07/2026
Phase II
Eli Lilly & Co.
Digestive System Diseases
Latvia, Portugal, Greece, France, Czechia, Italy, Poland, Slovakia, Hungary, Croatia, Lithuania
10/06/2026
Phase I/II
Aurinia Pharmaceuticals Inc.
Immune System Diseases
Poland, Spain, Denmark, Latvia, Italy
15/05/2026
Phase III
Generate Biomedicines Inc.
Respiratory Tract Diseases
Latvia, Hungary, Bulgaria, Romania, Portugal, Netherlands, Croatia, Germany, Greece, Czechia
12/05/2026
Phase III
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Neoplasms
Czechia, Sweden, Poland, Netherlands, Greece, Latvia, Finland, Norway, Belgium, Austria, Portugal, Romania, Italy, Estonia, France, Ireland, Germany, Spain, Bulgaria, Hungary
12/05/2026
Phase III
Takeda Development Center Americas Inc.
Musculoskeletal Diseases
Germany, Belgium, Spain, Czechia, Croatia, Portugal, Poland, Latvia, Bulgaria, France, Estonia, Hungary, Italy
12/05/2026
Phase III
Octapharma Pharmazeutika Produktionsgesellschaft mbH
Immune System Diseases
Czechia, Lithuania, Greece, Poland, Germany, Latvia, Bulgaria, Italy
11/05/2026
Phase II
Immunovant Sciences GmbH
Immune System Diseases
Italy, Greece, Germany, Hungary, Poland, Czechia, Netherlands, Spain, Belgium, Bulgaria, Latvia
05/05/2026
Phase III
Inhibikase Therapeutics Inc.
Cardiovascular Diseases
Spain, Poland, Italy, Belgium, Latvia, Denmark, Czechia, Germany, France, Netherlands, Portugal, Ireland, Austria, Greece, Lithuania
28/04/2026
Phase II
Regeneron Pharmaceuticals Inc.
Cardiovascular Diseases
Latvia, Belgium, France, Poland, Germany, Spain, Czechia
18/03/2026
Phase III
Liquidia Technologies Inc.
Respiratory Tract Diseases
Latvia, Germany, Italy, Czechia, France, Belgium, Portugal, Poland, Austria, Spain
11/03/2026
Phase III
Alvotech Swiss AG
Eye Diseases
Latvia, Slovakia, Czechia, Hungary, Poland, Bulgaria
06/03/2026
Phase III
Novartis Pharma AG
Nervous System Diseases
Denmark, Slovenia, Netherlands, Portugal, Ireland, Sweden, Croatia, Greece, Germany, Latvia, Czechia, Spain, Romania, Belgium, Austria, Lithuania, Slovakia, Poland, Estonia, Bulgaria, France, Italy, Hungary, Finland, Norway
03/03/2026
Phase III
MoonLake Immunotherapeutics AG
Musculoskeletal Diseases
Estonia, Croatia, Slovakia, Lithuania, Romania, Hungary, Germany, France, Latvia, Poland, Portugal, Greece, Czechia, Bulgaria, Finland, Spain
25/02/2026
Phase I
OPTERION Health AG
Not possible to specify
Latvia
09/01/2026
Phase II
Allrock Bio Inc.
Cardiovascular Diseases
Spain, Italy, Poland, France, Latvia, Germany
04/12/2025
Phase III
Glaxosmithkline Research & Development Limited
Respiratory Tract Diseases
Czechia, Greece, Latvia, Austria, Germany, Bulgaria, Romania, Italy
24/11/2025
Phase III
4d Molecular Therapeutics Inc.
Eye Diseases
Germany, Italy, Hungary, Bulgaria, Lithuania, France, Spain, Latvia, Portugal
21/11/2025
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-europe/country/latvia

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →

About this register

This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,905 trial records at the last sync on 21 Nov 2026, 03:17 UTC; this register shows the 2,554 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.

This page shows the 38 of those trials with a site in Latvia.

How many recently authorised EU trials have a site in Latvia?

38 of the 2,554 most recently authorised trials in this register list a site in Latvia; 27 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.

Summary by phase

Trials by phase (Latvia), 38 trials
PhaseTrialsShare
Phase III2771.1%
Phase II718.4%
Phase I25.3%
Phase I/II12.6%
Phase IV12.6%

Most active sponsors

Lead sponsors with the most trials (Latvia)
Lead sponsorTrials
Regeneron Pharmaceuticals Inc.4
Argenx2
4d Molecular Therapeutics Inc.1
Allrock Bio Inc.1
Alvotech Swiss AG1
Amgen Inc.1
Aurinia Pharmaceuticals Inc.1
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.1
Cardurion Pharmaceuticals Inc.1
Chiesi Farmaceutici S.p.A.1
Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.